---
title: "BioKangtai: Quadrivalent influenza virus split vaccine (for the population aged 6-35 months) has initiated Phase I clinical trials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263999798.md"
description: "BioKangtai: Quadrivalent influenza virus split vaccine (6-35 months age group) has initiated Phase I clinical trial"
datetime: "2025-11-03T11:14:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263999798.md)
  - [en](https://longbridge.com/en/news/263999798.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263999798.md)
generator: "portal-rs"
---

# BioKangtai: Quadrivalent influenza virus split vaccine (for the population aged 6-35 months) has initiated Phase I clinical trials

According to the Zhitong Finance APP, BioKangtai (300601.SZ) announced that the Phase I clinical trial preparation for its quadrivalent influenza virus split vaccine (for the 6-35 month age group) has been completed, and the Phase I clinical trial has commenced, with the first subject successfully enrolled recently. This quadrivalent influenza virus split vaccine, which has entered Phase I clinical trials, is suitable for the 6-35 month age group and can stimulate the body to produce immunity against influenza viruses, used for the prevention of influenza caused by vaccine-related strains

### Related Stocks

- [300601.CN](https://longbridge.com/en/quote/300601.CN.md)

## Related News & Research

- [15:53 ETFoundations to Freedom Named Primary Partner of Carson Ware for the Winn-Dixie 250 at Daytona International Speedway](https://longbridge.com/en/news/296823183.md)
- [Avcon, Butler National unit, delivers first King Air B200 mosquito-control aircraft modification](https://longbridge.com/en/news/297039183.md)
- [08:36 ETUltimate Men's HQ Launches Private Product-Match Education Experience](https://longbridge.com/en/news/296789283.md)
- [08:33 ETCunningham Security Systems Acquires S.W. Alarms, Expanding Service in Southeastern Massachusetts](https://longbridge.com/en/news/296788818.md)
- [Precision Peptide to showcase Recovery Patch at FitExpo Anaheim](https://longbridge.com/en/news/296902176.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**